ReP USP - Resultado da busca

Artigo de periodico
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance (2023)
Cuchel, Marina; Raal, Frederick J; Hegele, Robert A; Al-Rasadi, Khalid ; Arca, Marcello; Averna, Maurizio; Bruckert, Eric; Freiberger, Tomas; Gaudet, Daniel; Harada-Shiba, Mariko; Santos Filho, Raul Dias dos
Source: European heart journal. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, MULHERES, CONSENSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUCHEL, Marina et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. European heart journal, v. 44, n. 25, p. 2277-2291, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54630. Acesso em: 17 nov. 2024.
APA
Cuchel, M., Raal, F. J., Hegele, R. A., Al-Rasadi, K., Arca, M., Averna, M., et al. (2023). 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. European heart journal, 44( 25), 2277-2291. doi:10.1093/eurheartj/ehad197
NLM
Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, Bruckert E, Freiberger T, Gaudet D, Harada-Shiba M, Santos Filho RD dos. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance [Internet]. European heart journal. 2023 ; 44( 25): 2277-2291.[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54630
Vancouver
Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, Bruckert E, Freiberger T, Gaudet D, Harada-Shiba M, Santos Filho RD dos. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance [Internet]. European heart journal. 2023 ; 44( 25): 2277-2291.[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54630
Artigo de periodico
World Heart Federation Cholesterol Roadmap 2022 (2022)
Ray, Kausik K.; Ference, Brian A.; Severin, Tania; Blom, Dirk; Nicholls, Stephen J.; Shiba, Mariko H.; Almahmeed, Wael; Alonso, Rodrigo; Daccord, Magdalena; Ezhov, Marat
Source: Global heart. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, DISLIPIDEMIAS, ARTERIOSCLEROSE, CONSENSO, CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAY, Kausik K. et al. World Heart Federation Cholesterol Roadmap 2022. Global heart, v. 17, n. 1, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50460. Acesso em: 17 nov. 2024.
APA
Ray, K. K., Ference, B. A., Severin, T., Blom, D., Nicholls, S. J., Shiba, M. H., et al. (2022). World Heart Federation Cholesterol Roadmap 2022. Global heart, 17( 1). doi:10.5334/gh.1154
NLM
Ray KK, Ference BA, Severin T, Blom D, Nicholls SJ, Shiba MH, Almahmeed W, Alonso R, Daccord M, Ezhov M. World Heart Federation Cholesterol Roadmap 2022 [Internet]. Global heart. 2022 ; 17( 1):[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50460
Vancouver
Ray KK, Ference BA, Severin T, Blom D, Nicholls SJ, Shiba MH, Almahmeed W, Alonso R, Daccord M, Ezhov M. World Heart Federation Cholesterol Roadmap 2022 [Internet]. Global heart. 2022 ; 17( 1):[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50460
Artigo de periodico
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study (2022)
Tromp, Tycho R.; Hartgers, Merel L. ; Hovingh, G. Kees; Vallejo-vaz, Antonio J. ; Ray, Kausik K.; Soran, Handrean; Freiberger, Tomas; Bertolini, Stefano; Harada-shiba, Mariko; Blom, Dirk J.
Source: Lancet. Unidade: FM
Subjects: ESTUDOS DE COORTES, HIPERCOLESTEROLEMIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROMP, Tycho R. et al. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet, v. 399, n. 10326, p. 719-728, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50469. Acesso em: 17 nov. 2024.
APA
Tromp, T. R., Hartgers, M. L., Hovingh, G. K., Vallejo-vaz, A. J., Ray, K. K., Soran, H., et al. (2022). Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet, 399( 10326), 719-728. doi:10.1016/S0140-6736(21)02001-8
NLM
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-shiba M, Blom DJ. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study [Internet]. Lancet. 2022 ; 399( 10326): 719-728.[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50469
Vancouver
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-shiba M, Blom DJ. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study [Internet]. Lancet. 2022 ; 399( 10326): 719-728.[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50469
Artigo de periodico
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (2022)
Pradhan, Aruna Das; Glynn, Robert J.; Fruchart, Jean-Charles; Macfadyen, Jean G.; Zaharris, Elaine S.; Everett, Brendan M.; Campbell, Stuart E.; Oshima, Ryu; Amarenco, Pierre; Blom, Dirk J.
Source: New england journal of medicine. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADHAN, Aruna Das et al. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New england journal of medicine, v. 387, n. 21, p. 1923-1934, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50462. Acesso em: 17 nov. 2024.
APA
Pradhan, A. D., Glynn, R. J., Fruchart, J. -C., Macfadyen, J. G., Zaharris, E. S., Everett, B. M., et al. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New england journal of medicine, 387( 21), 1923-1934. doi:10.1056/NEJMoa2210645
NLM
Pradhan AD, Glynn RJ, Fruchart J-C, Macfadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk [Internet]. New england journal of medicine. 2022 ; 387( 21): 1923-1934.[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50462
Vancouver
Pradhan AD, Glynn RJ, Fruchart J-C, Macfadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk [Internet]. New england journal of medicine. 2022 ; 387( 21): 1923-1934.[citado 2024 nov. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50462
Artigo de periodico
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN (2015)
Simonneau, Gérald; Channick, Richard N.; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomás; Sastry, B. K. S.; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam; Rubin, Lewis J.
Source: European respiratory journal. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, ESTUDOS DE COORTES, FÁRMACOS (SISTEMA RESPIRATÓRIO), ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONNEAU, Gérald et al. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, v. 46, n. 6, p. 1711-1720, 2015Tradução . . Disponível em: https://doi.org/10.1183/13993003.00364-2015. Acesso em: 17 nov. 2024.
APA
Simonneau, G., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H. -A., Jansa, P., et al. (2015). Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, 46( 6), 1711-1720. doi:10.1183/13993003.00364-2015
NLM
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1183/13993003.00364-2015
Vancouver
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1183/13993003.00364-2015

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration